These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4737130)

  • 21. Etanercept treatment in myasthenia gravis.
    Rowin J
    Ann N Y Acad Sci; 2008; 1132():300-4. PubMed ID: 18567881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymectomy in the treatment of ocular myasthenia gravis.
    Roberts PF; Venuta F; Rendina E; De Giacomo T; Coloni GF; Follette DM; Richman DP; Benfield JR
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):562-8. PubMed ID: 11547310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of myasthenia gravis].
    Igata A
    Naika; 1970 Apr; 25(4):676-82. PubMed ID: 5423420
    [No Abstract]   [Full Text] [Related]  

  • 25. [Favorable results of plasmapheresis in severe myasthenia gravis].
    Blom RJ; Kuks JB; Westerterp-Maas A; Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(8):381-4. PubMed ID: 9157298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of severe forms of myasthenia with prednisolone and triamcinolone].
    Gekht VM; Kuzin MI; Kuralsein MG; Shagal DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(6):815-9. PubMed ID: 1217381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Large dose of prednisone in the treatment of the oculomuscular type of myasthenia gravis].
    Wang DC
    Zhonghua Yan Ke Za Zhi; 1984 Jul; 20(4):245-7. PubMed ID: 6439528
    [No Abstract]   [Full Text] [Related]  

  • 28. [Massive prednisolone administration in myasthenia gravis--electrophysiological examination].
    Yanagizawa N; Shoji S; Tsukagoshi H; Toyokura Y
    Nihon Rinsho; 1973 Feb; 31(2):321-6. PubMed ID: 4737112
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of myasthenia gravis with immunosuppressants (author's transl)].
    Yang RM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):23-5. PubMed ID: 7307783
    [No Abstract]   [Full Text] [Related]  

  • 30. [Principles of the complex therapy of myasthenia].
    Kuzin MI
    Klin Med (Mosk); 1969 Nov; 47(11):6-11. PubMed ID: 5380040
    [No Abstract]   [Full Text] [Related]  

  • 31. Childhood myasthenia gravis.
    Berkovitz S; Belkin M; Tenenbaum A
    J Pediatr Ophthalmol; 1977; 14(5):269-73. PubMed ID: 925839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Some metabolic and regulatory aspects in myasthenia].
    Hrazdira CL; Vágner B
    Cesk Neurol; 1968 Jul; 31(4):280-5. PubMed ID: 4306025
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myasthenia gravis patients with pyramidal signs. Report of 5 cases].
    Xu XH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Oct; 20(5):280-2. PubMed ID: 3502463
    [No Abstract]   [Full Text] [Related]  

  • 34. [Myasthenia gravis in Santo Tomás Hospital 1990-1997].
    Frago G; Gracia F; Chang E; Andrade Alegre R
    Rev Med Panama; 1998 Sep; 23(2):15-9. PubMed ID: 11214554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study of 100 cases of myasthenia gravis].
    Zhang ZX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Aug; 17(4):214-9. PubMed ID: 6536451
    [No Abstract]   [Full Text] [Related]  

  • 36. [Myasthenia gravis].
    Satoyoshi E; Nakazato H
    Naika; 1971 Jun; 27(6):1440-4. PubMed ID: 4326414
    [No Abstract]   [Full Text] [Related]  

  • 37. [Application of germine alkaloid in myasthenia gravis. 2. Clinical application of germine monoacetate].
    Fukushima K; Toyama H
    Nihon Rinsho; 1973 Feb; 31(2):336-40. PubMed ID: 4737115
    [No Abstract]   [Full Text] [Related]  

  • 38. [Research progress on a new potassium channel-blocking agent--4-aminopyridine].
    Zheng W; Zhang YP
    Sheng Li Ke Xue Jin Zhan; 1986 Jul; 17(3):254-8. PubMed ID: 2432655
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of myasthenia gravis with germine diacetate.
    Flacke W; Caviness VS; Samaha FG
    N Engl J Med; 1966 Dec; 275(22):1207-14. PubMed ID: 5921854
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of myasthenia gravis in pregnancy].
    Pezzoli G; Bonfadini Bossi E; Rella R
    Minerva Ginecol; 1980; 32(1-2):21-6. PubMed ID: 6245392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.